The Catalyst

Most Recent Posts

12.15.14 | By Allyson Funk

What if the information you need to make the most informed decision is not available?

12.11.14 | By Randy Burkholder

Today, I had the chance take part in a Google+ Hangout organized by TEDMED. A part of TEDMED’s Great Challenges series, the Hangout, titled, “A Delicate Balance: How Can We Rightsize Treatment Costs,?” was a lively discussion among stakeholders from across the health care ecosystem.

12.11.14 | By Jocelyn Ulrich

Setting the record straight about participation in clinical trials.

12.11.14 | By Mark Grayson

“When compounded products are not made according to strict quality standards appropriate for their scale of production, the results can be deadly.”  Six public health organizations wrote this to FDA Commissioner Hamburg to voice strong support on FDA’s robust enforcement of the federal law on compounding.

Principles on Conduct of Clinical Trials
12.10.14 | By Dr. Bill Chin

Researchers in biopharmaceutical companies strive to discover and develop new medicines and vaccines that will help people to live longer, healthier lives.  They go to work every day knowing that patients with life-threatening diseases live with the hope that tomorrow will bring a new medicine that will extend and improve lives.

12.05.14 | By Holly Campbell

Following several years of modest growth, a new study published in Health Affairs reports a record low health care spending increase of 3.6 percent in 2013. The last time the annual growth rate was any smaller, Dwight Eisenhower was President and a gallon of milk cost 49 cents.  The year was 1960.

12.01.14 | By George Hanna, M.D.

Today is World AIDS Day, and we’re examining the tremendous progress we’ve made turning what was once considered a virtual death sentence into a chronic condition. The fact that the death rate for HIV/AIDS patients has decreased nearly 85 percent since its peak in the mid-1990s is a testament to the dedicated researchers who worked tirelessly to develop new medicines like those that make up highly active antiretroviral therapy (HAART) that transformed how we treated the disease.

11.25.14 | By Brooke Ringel

Today, United States Trade Representative Michael Froman is in India to participate in the U.S. – India Trade Policy Forum. Since Indian Prime Minister Narendra Modi’s election in May, Indian and U.S. leaders have held several meetings to further the relationship between our countries

11.25.14 | By Allyson Funk

With Black Friday just a few days away, holiday shopping madness is kicking into full gear. Deciding what to buy, comparing prices and ultimately making a decision can be stressful. The best advice for Black Friday also applies to shopping for health insurance:

Shop early Compare options Choose the best for you and your family

11.24.14 | By Dr. Fran Cogen

Every November is Diabetes Awareness Month – a time to reflect on the progress we have made in treating the nearly 26 million Americans with the chronic disease. We take stock of new treatments, awareness, better adherence to diabetes medications and ask ourselves, “what more can we do?” to better treat this serious public health concern.

11.21.14 | By Tina Stow

Ryan Hohman of Friends of Cancer Research authored a guest post this week that echoed our own thoughts stating, “Open collaboration is often the best route to innovation and improved outcomes for patients.”

11.20.14 | By Robert Zirkelbach

Since 2000, biopharmaceutical companies have brought more than 450 new innovative medicines to the U.S. market, resulting in significant progress against some of the most costly and challenging diseases. Yet, prescription drug spending in the U.S. has remained constant and federal projections show growth is in-line with health care spending through the next decade.  

11.20.14 | By Ryan Hohman, JD

November is National Lung Cancer Awareness Month, a time to reflect upon the disease’s enormous human cost.  This month, some 18,600 Americans will be diagnosed with lung cancer and approximately 13,000 Americans will be killed by it. It is, by a wide margin, the most common cause of cancer death in the United States.

11.20.14 | By Allyson Funk

Earlier this week, the Kaiser Family Foundation released new research about the deductibles in different health insurance exchange plans. The study found for bronze or silver plans patients often have to pay thousands of dollars out of pocket due to high combined deductibles.

11.19.14 | By Robert Zirkelbach

Patients are living longer, healthier lives thanks to biopharmaceutical innovation.  But, as evidenced by a new study released yesterday by the Tufts Center for the Study of Drug Development, the road to bringing a new FDA-approved medicine to patients is long and the costs are formidable.

Pages